ANKRD1 (Ankyrin Repeat Domain 1), also known as CARP (CAncer-related Regulated by p53) or DARP32 (Ankyrin repeat domain protein 32), is a transcriptional coactivator protein encoded by the ANKRD1 gene located on chromosome 10. ANKRD1 contains four ankyrin repeat domains that mediate protein-protein interactions and play crucial roles in transcriptional regulation, cellular stress responses, and cytoskeletal organization.
ANKRD1 is a 331-amino acid protein with a molecular weight of approximately 36 kDa. The protein contains:
- N-terminal transcriptional activation domain - Contains acidic residues that interact with transcription factors including p53, YAP1, and myocardin
- Ankyrin repeat domain (4 repeats) - Each repeat consists of approximately 33 amino acids forming a helix-turn-helix structure that mediates protein-protein interactions
- C-terminal region - Contains nuclear localization signals (NLS) and regulatory sequences
The crystal structure of ANKRD1 has been solved (PDB: 1WC7, 2JSM), revealing the characteristic ankyrin repeat fold with conserved hydrophobic cores.
ANKRD1 functions as a transcriptional coactivator through multiple mechanisms:
- p53 pathway modulation: ANKRD1 interacts with p53 tumor suppressor protein, enhancing its transcriptional activity and promoting p53-dependent gene expression. This interaction occurs through the N-terminal domain of ANKRD1 and the DNA-binding domain of p53.
- YAP1/TAZ signaling: ANKRD1 modulates the Hippo pathway effector YAP1 (Yes-associated protein 1), influencing cell proliferation and survival signals
- Myocardin interaction: ANKRD1 regulates smooth muscle and cardiac muscle gene expression through interactions with myocardin family transcription factors
- DNA damage response: ANKRD1 is upregulated in response to DNA damage and oxidative stress, serving as a stress-responsive gene
- Hypoxia response: Hypoxia-inducible factor (HIF) pathway activation induces ANKRD1 expression
- Mechanical stress: ANKRD1 responds to mechanical stretching and load in cardiac and skeletal muscle
- Titin interaction: ANKRD1 binds to the giant protein titin (TTN) in cardiac muscle, forming part of the sarcomeric M-band complex
- Actin binding: Modulates actin cytoskeleton dynamics in various cell types
- Nuclear envelope: Associates with nuclear envelope proteins affecting nuclear structure
ANKRD1 plays complex roles in Alzheimer's disease pathogenesis through multiple pathways:
Neuronal Survival Regulation
- ANKRD1 modulates p53-mediated apoptotic pathways in neurons. In AD brains, altered ANKRD1 expression affects the balance between pro-survival and pro-apoptotic signals. Studies have demonstrated that ANKRD1 can protect neurons against amyloid-beta-induced cell death through p53-dependent mechanisms.
- The protein interacts with casein kinase 2 (CK2) and influences downstream phosphorylation cascades that regulate neuronal viability
Amyloid-beta Metabolism
- Evidence suggests ANKRD1 expression is altered in response to amyloid-beta accumulation
- May influence amyloid precursor protein (APP) processing through indirect mechanisms
Tau Pathology
- ANKRD1 may modulate tau phosphorylation through interactions with kinase and phosphatase systems
- Altered expression observed in brain regions affected by neurofibrillary tangles
Dopaminergic Neuron Protection
- ANKRD1 protects against 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in dopaminergic neurons
- The protein is involved in mitochondrial quality control mechanisms relevant to PD pathogenesis
- ANKRD1 expression is modulated by PINK1 and Parkin, key proteins in familial Parkinson's disease
Mitochondrial Function
- ANKRD1 localizes to mitochondria under stress conditions
- Modulates mitochondrial membrane potential and reactive oxygen species (ROS) production
- Involved in mitochondrial dynamics (fusion/fission) regulation
- ANKRD1 expression is altered in motor neuron diseases
- May influence TDP-43 proteinopathy through transcriptional regulation
- Associated with stress granule formation in ALS models
¶ Stroke and Cerebral Ischemia
Ischemic Response
- ANKRD1 is rapidly induced following cerebral ischemia/reperfusion injury
- Serves as a damage-associated molecular pattern (DAMP) signal
- May have dual roles - both protective and detrimental depending on context and timing
Neuroprotection Mechanisms
- p53-dependent anti-apoptotic effects in early phases
- Modulation of inflammatory responses post-stroke
ANKRD1 has been investigated as a biomarker for:
- Cardiac injury: Serum ANKRD1 levels correlate with cardiac damage
- Neuronal injury: Cerebrospinal fluid (CSF) ANKRD1 may indicate neuronal damage
- Disease progression: Potential marker for monitoring neurodegeneration progression
- Small molecule modulators: Compounds that enhance ANKRD1 expression or activity
- Gene therapy: Viral vector-mediated ANKRD1 delivery to protect neurons
- Protein-protein interaction inhibitors: Targeting ANKRD1-p53 interaction for specific outcomes
Studying ANKRD1 in neurodegeneration involves:
- Gene expression analysis: qRT-PCR, RNA-seq to measure ANKRD1 mRNA levels
- Protein detection: Western blot, immunohistochemistry in brain tissue
- Functional studies: siRNA knockdown, CRISPR-Cas9 knockout in cell models
- Animal models: Transgenic mice with neuron-specific ANKRD1 overexpression or deletion
¶ Interactions and Pathways
ANKRD1 interacts with multiple proteins and participates in several signaling pathways:
| Partner Protein |
Interaction Type |
Functional Consequence |
| p53 |
Direct binding |
Transcriptional coactivation |
| YAP1 |
Direct binding |
Hippo pathway modulation |
| Titin |
Structural |
Sarcomere organization |
| CK2 |
Phosphorylation |
Activity regulation |
| MDM2 |
Ubiquitination |
Protein stability |